Join our daily newsletter At The Bell to receive exclusive market insights
- Epsilon Healthcare’s (EPN) medicinal cannabis subsidiary, Tetra Health, launches a new clinic for in-person consultations in Melbourne
- Tetra has partnered with TerryWhite Chemmart Hawthorn (TWCH) to service growing demand in Victoria
- The collaboration gives patients visiting TWCH the option to consult a Tetra doctor and receive their scripts and medication at one location
- Tetra has seen significant growth in revenue and patient numbers since being acquired by EPN last year, with further east coast expansions to follow
- Epsilon Healthcare shares closed flat at 16 cents apiece on August 19
Epsilon Healthcare’s (EPN) medicinal cannabis group, Tetra Health, has launched a new clinic for in-person consultations in Melbourne, Victoria.
Tetra has partnered with TerryWhite Chemmart Hawthorn (TWCH) — reportedly one of the largest medicinal cannabis-dispensing pharmacies in Australia — to service growing demand in the state.
The collaboration will give patients visiting TWCH the option to consult a Tetra doctor, and receive their scripts and medication at one location.
EPN said patients would see similar out-of-pocket costs to its telethealth offering thanks to access to Medicare rebates on treatment.
Epsilon Healthcare CEO Jarrod White commented on the partnership.
“We see expanding into in-person clinics as being a core element of Tetra Health’s future growth and, to that end, are pleased to see this partnership with TerryWhite Chemmart Hawthorn come to fruition,” he said.
TWCH proprietor Andrew Farmer said the arrangement would further grow the business and better service patients.
“We want to use our combined expertise and streamline the process for our patients looking to access medical cannabis treatments,” he said.
“Having worked with Tetra Health now for over 12 months as one of their preferred pharmacies, we see that Tetra’s patient-centric ethos aligns with our team’s values.”
EPN said its subsidiary had experienced significant growth since it was acquired last year and achieved a record six-month run rate in the first half of 2021, exceeding $750,000 for the first time.
Epsilon intends the new clinic to replace the company’s affiliation with the Astrid Dispensary, with the same Tetra doctor to transfer from Astrid to TWCH to provide consistency for patients.
Further expansions are targeted in Sydney and Brisbane later this year.
Epsilon Healthcare shares closed flat at 16 cents apiece on August 19.
